Pharmacogenetic testing among patients with depression in a US managed care population
Abstract Actionable drug–gene pairs relevant to depression treatment include CYP2D6 and CYP2C19 with specific antidepressants. While clinical use of pharmacogenetic testing is growing, little is known about pharmacogenetic testing for depression treatment in managed care. We determined the incidence...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2022-07-01
|
| Serie: | Clinical and Translational Science |
| Accesso online: | https://doi.org/10.1111/cts.13279 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|